A randomised controlled trial of iMindTime digital health: A comprehensive mindfulness and loving kindness meditation wellbeing digital health program.

INTERVENTION: A randomised controlled trial will be used to investigate the effectiveness of the iMindTime digital health program, offered through My Digital Health (parent platform). People taking part in the study will be randomly allocated to either an immediate access to the program, or delayed access (7‐week delay). The iMindTime digital health program consists of six brief sessions delivered over 3 weeks, designed to make an individual more mindful or increase awareness of moment‐to‐moment experiences (e.g., thoughts, feelings, sensations) and simply accept what is there without wanting it to change in any way. Participants will be asked to spend three days on each session before moving onto the next session. Each session will take 5‐10 minutes to read and its user friendly and interactive components are designed to keep the user engaged. To consolidate learning, participants will be given activities (10‐20 minutes per day) to complete offline to practise the principles of specific mindfulness exercises (i.e., mindfulness of the breath, mindfulness of body sensations, mindfulness of emotions, mindfulness of sounds, mindfulness of thoughts and loving kindness meditation) and asked to provide simple feedback on this practise at the next session. Participants will also receive automated emails (e.g., remind them to log on, when to complete scheduled assessments) and will be asked several questions during the study period to monitor their progress. The iMindTime sessions include text, graphics, audio, quizzes, and downloads. iMindTime can be accessible via web, mobile or tablet devices. The iMindTime program is housed within the participant's ‘My Digital Health’ dashboard. My Digital Health is the parent platform that houses a variety of digital health programs. Via the participant’s dashboard, they are able to access several resources. This includes: My Dashboard, My Inbox, My Daily Monitoring, My Progress Graphs, My Timeline, My Profile and My Tutorial. Participants randomised to the iMindTime digital health (immediate access) group will complete a pre‐intervention assessment (Week 0), during intervention (Week 2) assessment, post‐intervention assessment (Week 4) and a 1 month follow‐up assessment (Week 8). Participants randomised to the delayed access group will complete the same assessment phases and will be given access to iMindTime digital health program following the 1 month follow‐up assessment (Week 8). However, the delayed access group will be asked to complete the post intervention assessment after they have completed the iMindTime digital health program (Week 11). While the during, post‐intervention and follow up assessments are scheduled (and access to the program has been provided), participants will not be able to access the program until they have completed the scheduled assessments (or after the expiry time to complete the assessment has lapsed). Participants will retain access to the program until Week 20. Participant engagement with the program will be obtained through by passive analytic data (e.g., what pages / strategies they visited and when), as well as reviewing the completion of daily mood and lifestyle events surveys and scheduled intervention assessments. CONDITION: Anxiety Depressive symptoms Mental Wellbeing Stress PRIMARY OUTCOME: Anxiety symptoms will be measued using the DASS‐21 Depressive symptoms will be measured using the DASS‐21 Stress symptoms will be measured using the DASS‐21 INCLUSION CRITERIA: Participants must be 18 years or older. SECONDARY OUTCOME: Affective styles will be measured using the ASQ Alcohol consumption levels (self‐developed questions) and followed up with CAGE‐AID questions if high alcohol consumption is indicated Chronic physical illness diagnosis questions (self developed) Current use of prescribed medication(s) question (self‐developed) Drug use (self‐developed questions) and followed up with CAGE‐AID questions if high use of drugs is indicated. General psychological distress will be measured using the K10 Intervention satisfaction, including engagement, will be measured using the TSQ Mental health condition diagnosis questions (self developed) Mental Health Rating Question ‐ 6 point scale (self developed) Mental health wellbeing will be measured using the MCH‐SF Optimism will be measured using the LOT‐R Personality traits will be measured using the TIPI Physical activity levels using single item questions (self developed) Physical Health Rating Question ‐ 6 point scale (self developed) Quality of Life Rating Question ‐ 6 point scale (self developed) Sleep quantity and quality questions (self‐developed and 4 ISI items used). Social Connectedness Rating question using a 5 point scale (self developed) Time perception as measured by the Time Dilation Test (self‐developed) Use of mental health services for a mental health condition questions (self developed) Use of services for a physical health condition questions (self developed)